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A B S T R A C T
Background: Beta-blockers are used to control the heart rate prior to coronary computed tomography
(CT) angiography. However, in-hospital administration is time-consuming, and it is hard to decrease the
heart rate to <60 beats per minute (bpm) when the initial heart rate is increased. In this study, we
examined whether the single administration of long-acting b-blocker at bedtime before angiography is
effective for achieving the target heart rate.
Methods and results: A total of 314 consecutive patients with a resting heart rate >60 bpm who
underwent coronary CT angiography were retrospectively collected. Either bisoprolol or atenolol was
orally administered the night before to 166 patients (beta group), and no additional medication was
administered to the other 148 patients (control group). When the heart rate was >60 bpm on arrival, a
b-blocker or verapamil was orally administered at the discretion of the physician. Although the baseline
heart rate was not signiﬁcantly different between the groups, the b-blocker treatment the night
before signiﬁcantly reduced the heart rate compared to control group upon arrival at the hospital and at
the time of angiography. The rate of achievement of a heart rate 60 bpm on arrival at the hospital was
signiﬁcantly higher in the beta group, and even after the additional treatment.
Conclusions: Bedtime administration of a long-acting b-blocker the night before coronary CT
angiography is an effective option to achieve the target heart rate at the time of examination.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Coronary computed tomography (CT) angiography has become
an established clinical technology for the evaluation of coronary
artery disease, with high sensitivity and high negative predictive
value in selected patients. However, the image quality remains
highly dependent on both the regularity of the cardiac rhythm and
the heart rate [1–6]. It is therefore recommended that the heart
rate be controlled, ideally at 60 beats per minute (bpm) for both
optimal image quality and to reduce the radiation exposure,
especially when single-source CT scanners are used. b-blockers* Corresponding author at: Department of Cardiology, Saga-ken Medical Centre
Koseikan, 400 Nakabaru, Kase, Saga 840-8571, Japan. Tel.: +81 952 24 2171;
fax: +81 952 29 9390.
E-mail addresses: k-sadamatsu@umin.ac.jp,
sadamatsu-k@koseikan.jp (K. Sadamatsu).
http://dx.doi.org/10.1016/j.jjcc.2014.07.007
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsremain the ﬁrst-line option to reduce the heart rate prior to
coronary CT angiography, although ivabradine, a novel selective
heart rate-lowering drug, has been developed and was recently
reported to be superior to a b-blocker [7–9]. Several b-blocker
administration protocols with oral and/or intravenous applications
have been proposed [10]; however, the in-hospital administration
is time-consuming, and could not decrease the heart rate to
60 bpm in several cases [11]. Therefore, it is necessary to
establish an easier and more efﬁcient protocol to achieve the target
heart rate.
Roberts et al. [2] reported that achieving the target heart rate
becomes harder when the initial heart rate is increased, especially
when it is >80 bpm, although b-blockers are still effective. Thus, it
may be useful to reduce the heart rate prior to the arrival at a
hospital. While short-acting b-blockers are preferred for in-
hospital administration at most centers, the long-acting
b-blockers are also safe and have a high potency for reducing
the heart rate. In this study, we examined whether the single reserved.
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before angiography is effective to achieve the target heart rate
reduction.
Methods
From April 2010 to March 2011, 409 consecutive patients with
suspected or known coronary artery disease who underwentFig. 1. A diagram showing the steps involved in the coronary computed tomography (C
patients who were administered an oral b-blocker the night before served as the beta gro
department, the heart rate (HR) was checked, and additional medication was administer
with paroxysmal supra-ventricular tachycardia (PSVT).elective coronary CT angiography at our institution were
retrospectively evaluated in this study (Fig. 1). We excluded 94
patients because their resting heart rates at presentation were
60 bpm. All patients gave informed consent for the procedure,
and the institutional review board approved this study.
After the examination of the patient’s clinical history, regular
medication, contraindications to b-blockers and an electrocardio-
gram, one of eight cardiologists or one cardiovascular surgeon inT) study. Of all of the patients whose heart rate was >60 bpm at presentation, 166
up, and the others served as a control group. When patients arrived at the radiology
ed to patients with a heart rate >60 bpm, except for one patient in the control group
Fig. 2. The heart rates (bpm) of the control group and the beta group at baseline,
upon arrival at the hospital (arrival) and just before the image acquisition
(pre-imaging). *p < 0.01 vs the control group.
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the patient for coronary artery disease, and selected one of two
preparative regimens at their discretion: an oral b-blocker was
administered the night before the procedure in 166 patients
(beta group), and no additional medication was administered to
149 patients (control group). Physicians selected either biso-
prolol (5 mg) or atenolol (25 mg) for the bedtime administra-
tion, and bisoprolol was used for 141 patients and atenolol for
25 patients. The prescription rates of the bedtime b-blocker
were different among the nine physicians, and the range of the
rate was from 0% to 87.5% (55.7  29.7%). The patients arrived at
the radiology department in the morning, and their blood pressure
and heart rate were checked. We excluded one patient in the
control group from the analysis, because the electrocardiogram
showed paroxysmal supra-ventricular tachycardia. The target
heart rate was deﬁned as 60 bpm, and the patients with a heart
rate above this threshold were treated with oral metoprolol
(20 mg), which was used preferentially because of its fast onset
and short half-life. Oral verapamil (40 mg) instead of metoprolol
was administered to nine patients in the beta group and 28
patients in the control group because of pulmonary disease,
coronary spasm, prior b-blocker administration, or for unknown
reasons in 6, 20, 8, and 3 patients, respectively. One more
additional administration of metoprolol or verapamil was permit-
ted when the heart rate remained >60 bpm. These preparations
could be modiﬁed at the discretion of the physicians. Their blood
pressure and heart rate were also recorded just before the image
acquisition (pre-imaging).
All patients underwent coronary CT angiography with a
64-slice scanner (Aquilion 64 MDCT scanner; Toshiba Medical
Systems, Tochigi, Japan) following the institutional standard
protocol. We recorded all adverse events during and after the
examination, and told the patients to call us if they had any new
signs or symptoms.
The quantitative data are presented as the mean values  SD,
and qualitative data are presented as frequencies. Continuous
variables between the 2 groups were compared using the Mann–
Whitney test. Categorical variables were compared with the chi-
square test. A multivariate logistic regression analysis was
developed to identify the clinical factors associated with the
achievement of the target heart rate just before the image
acquisition using a backwards stepwise procedure. The clinical
factors, which are shown in Table 1, were eliminated in a stepwise
manner when they were not signiﬁcant at a p-value of 0.05. All
probability values were 2-tailed, and a value of p < 0.05 was
considered to be statistically signiﬁcant. All statistical analyses
were performed with the SPSS software program (SPSS, Inc.,
Chicago, IL, USA).Table 1
Patient characteristics.
Beta Control p-value
n = 166 n = 148
Age 68.1  10.3 69.8  9.9 0.13
Male 92 (55) 96 (65) 0.09
Diabetes 56 (34) 41 (28) 0.25
Hypertension 92 (55) 73 (49) 0.28
Dyslipidemia 80 (48) 64 (43) 0.38
Smoking 40 (24) 29 (20) 0.33
Prior MI or PCI or CABG 39 (23) 65 (44) <0.01
Asthma 1 (1) 8 (5) 0.01
Beta blocker therapy 7 (4) 15 (10) 0.04
Baseline heart rate (bpm) 73.3  9.4 73.5  8.5 0.83
Data are expressed as the means  SD or as the number (percentage).
MI, myocardial infarction; PCI, percutaneous coronary intervention; CABG,
coronary artery bypass graft.Results
The patients’ baseline characteristics are summarized in
Table 1. There was no difference in the baseline heart rate between
the two groups; however, the heart rate on the arrival at the
radiology department was signiﬁcantly lower in the beta group
(61.5  8.9 bpm vs 71.6  11.0 bpm, p < 0.01) (Fig. 2). Additional
treatment with oral metoprolol or verapamil for patients whose heart
rate was >60 bpm upon arrival was administered to 25.3% of the
patients in the beta group and 67.6% of those in the control group.
Although the treatment decreased the heart rate in the control group,
there was still a signiﬁcant difference between the 2 groups
(57.2  8.0 bpm vs 61.0  9.6 bpm, p < 0.01). The rate of achieve-
ment of the target heart rate was higher in the beta group upon arrival
(58.4% vs 16.9%, p < 0.01), and even after the additional treatment
with metoprolol or verapamil (74.1% vs 57.4%, p < 0.01) (Fig. 3). There
were no signiﬁcant differences in the systolic blood pressure between
the 2 groups (Fig. 4). The multivariate logistic regression analysis
showed that gender, the baseline heart rate, bedtime b-blocker
administration, and hypertension were signiﬁcantly associated withFig. 3. The rate (%) of achievement of the target heart rate of 60 bpm upon arrival
at the hospital (arrival), and after the additional treatment (additional).
Fig. 4. The systolic blood pressures (mmHg) of the control group and the beta group
upon arrival at the hospital (arrival) and just before the image acquisition
(pre-imaging).
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acquisition (Table 2). No adverse events requiring hospitalization
occurred due to the treatment with the b-blockers.
Discussion
Heart rate control is important to optimize the image quality of
the coronary arteries and to reduce radiation exposure for patients
who undergo coronary CT angiography [1–4,6,12]. Although some
scanners with faster gantry rotations or dual-source conﬁgura-
tions, which were recently developed, can obtain diagnostic image
quality at higher heart rates [13], the scan quality is generally
insufﬁcient at higher heart rates. Most centers control the heart
rate with b-blockers administered either orally or intravenously in
order to achieve a target heart rate 60 or 65 bpm; however, the
rate of achievement of the target heart rate remains dissatisfactory.
Oral metoprolol administration led to a decrease to the target
heart rate in only 35–65% of patients [2,5,9,11,12]. While
ivabradine, a selective heart rate-lowering agent, was reported
to be superior to b-blockers, the rate of achievement was 37–60%
[7–9]. In addition, intravenous administration of esmolol reduced
the heart rate to 65 bpm in about 65% of cases. Although the rate
of achievement could not be compared directly because the patient
selection profoundly inﬂuences the achievement of the targetTable 2
The results of the multivariate logistic regression analysis for the achievement of a
target heart rate 60 bpm.
Odds ratio 95% conﬁdence
interval
p-value
Male gender 0.56 0.34–0.94 0.03
Baseline HR (bpm) 0.95 0.92–0.97 <0.01
Bedtime administration 2.29 1.38–3.80 <0.01
Hypertension 0.54 0.33–0.88 0.02
The multivariate logistic regression analysis was performed using the
achievement of the target heart rate as a dependent variable, and the age,
gender (male), baseline heart rate (HR), bedtime b-blocker administration,
prior coronary intervention or myocardial infarction, diabetes, hypertension,
dyslipidemia, asthma, smoking, and chronic b-blocker treatment as indepen-
dent variables.heart, our protocol of bedtime administration of long-acting
b-blocker the night before the examination sufﬁciently decreased
the heart rate of patients.
Although an intravenous administration protocol is associated
with greater heart rate reduction, the use of the intravenous
route is time-consuming, and is associated with high costs and
additional care by medical staff. Thus, oral application may
be preferable. However, the administration after arrival at the
hospital is also time-consuming. On the other hand, when the
target heart rate is achieved on arrival at the hospital, no further
preparation prior to image acquisition by CT is needed. Conse-
quently, the in-hospital stay of patients is shortened and additional
care by medical staff is not required. Therefore, our protocol
employing the bedtime administration of a long-acting b-blocker
the night before the examination has a major advantage compared
to the in-hospital administration protocols.
There are some important limitations associated with our
study. First, our study was a retrospective study performed at a
single institution. The non-randomized design might have led to
some bias when selecting the preparation for patients. However,
there were no signiﬁcant differences in the patients’ background
which might have affected the heart rate reduction with the
bedtime administration, and the multivariate logistic regression
analysis showed that the bedtime administration of a b-blocker
was an independent predictor for achieving the target heart rate.
Therefore, the bedtime protocol might be feasible for almost all
patients undergoing coronary CT angiography. In fact, the
variations in the prescription rates among the physicians might
indicate that the physicians’ preference plays a major role in the
drug administration. Second, we did not investigate the image
quality and radiation exposure doses in the bedtime administra-
tion protocol compared to the conventional protocol. However,
these parameters are difﬁcult to evaluate precisely in individual
cases, and current publications recommend reducing the heart
rate to 60 bpm to ensure both optimal image quality and to
reduce the radiation exposure. Third, the most appropriate dose
of b-blockers for bedtime administration was not determined in
the present study. Fourth, we could not retrospectively determine
the precise minor side effects of b-blockers due to the fact that
some descriptions found in the records were vague, while there
were no major adverse events requiring hospitalization related to
b-blockers. As a result, only a few symptoms were thus found to
be related to the bedtime administration.
In this study, we have demonstrated that the single
administration of a long-acting b-blocker at bedtime the night
before the examination was associated with a high rate of
achievement of a target heart rate of 60 bpm in patients who
underwent coronary CT angiography. This cost-effective and
easy protocol is an effective and feasible preparation for patients
who undergo coronary CT angiography.
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